Overengineering
December 4, 2012
“Overengineering” is anathema to most product manufacturers. Generally, manufacturers desire to put no more time and money into a product than is necessary. They decide upon a reasonable lifespan for a product, and then they use materials and parts that, with rare exception, have been proven to last that long. They do not care to produce a product that lasts longer than the consumer desires; they do not want to invest resources where they won’t see a return.
An exception to this general rule is invoked by those manufacturing products which, if they break, will kill or maim people. Airplanes are the classic example: they’re built with multiple redundancies and with materials and parts that have been tested to last much longer than necessary. The potential for catastrophic loss of life demands this. They will use a part that’s tested to last 20 years, and replace it after ten years just to be safe.
I suspect that some observers of the MHSAA’s recent campaign to increase sports safety training for coaches and modify playing rules that may endanger participants are critical that we’re asking too much, that we’re doing more than is necessary. But frankly, that’s exactly what we intend. When it comes to participant safety, overengineering of policies and procedures ought to be our goal.
Cardiac Screening
October 31, 2014
Sudden death among 12 to 25-year-olds is “a low event rate occurrence.”
“There is insufficient information to support the view that ECGs in asymptomatic young people for cardiac disease is appropriate or possible on a national basis for the United States, in competitive athletics or in the general population.”
“At present, there is no mechanism available in the United States to effectively create national programs of such magnitude, whether limited to athletics or including the wider population of all young people.”
“There is insufficient evidence that particularly large-scale/mass screening initiatives are feasible or cost effective within the current US healthcare infrastructure . . .”
“The ECG . . . cannot be regarded as an ideal or effective test when applied to large healthy populations.”
“An additional, but unresolved, ethical issue concerns whether students who voluntarily engage in competitive athletic programs should have advantage of cardiovascular screening, while others who choose not to be involved in such activities (but may be at the same or similar risk) are in effect excluded from the same opportunity.”
The AHA’s Sept. 14 AHA writing group “does not believe the available data support significant public health benefit from using the 12-lead ECG as a universal screening tool. The writing group, however, does endorse the widespread dissemination of automated external defibrillators which are effective in saving young lives on the athletic field and elsewhere.”